Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sepideh Zununi Vahed, Nazanin Fathi, Mohammad Samiei, Solmaz Maleki Dizaj & Simin Sharifi. (2019) Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles. Journal of Drug Targeting 27:3, pages 292-299.
Read now
Read now
Fagner Santos do Carmo, Eduardo Ricci-Junior, Cristal Cerqueira-Coutinho, Marta de Souza Albernaz, Emerson Soares Bernardes, Sotiris Missailidis & Ralph Santos-Oliveira. (2017) Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations. International Journal of Nanomedicine 12, pages 53-60.
Read now
Read now
Driton Vllasaliu, Robyn Fowler & Snow Stolnik. (2014) PEGylated nanomedicines: recent progress and remaining concerns. Expert Opinion on Drug Delivery 11:1, pages 139-154.
Read now
Read now
Articles from other publishers (14)
Yaru Li, Meiyu Feng, Tao Guo, Zheng Wang & Yanjun Zhao. (2023) Tailored Beta‐Lapachone Nanomedicines for Cancer‐Specific Therapy. Advanced Healthcare Materials 12:20.
Crossref
Crossref
Atena Mansouri, Thozhukat Sathyapalan, Prashant Kesharwani & Amirhossein Sahebkar. 2023. Aptamers Engineered Nanocarriers for Cancer Therapy. Aptamers Engineered Nanocarriers for Cancer Therapy
219
235
.
Lu Zhou, Yajie Zhang & Yong Ma. (2022) Construction of a redox-responsive drug delivery system utilizing the volume of AS1411 spatial configuration gating mesoporous silica pores. Nanoscale Advances 4:19, pages 4059-4065.
Crossref
Crossref
Huma Khan, Vaidehi Makwana, Sofia Nascimento dos Santos, Carlos Eduardo Bonacossa de Almeida, Ralph Santos-Oliveira & Sotiris Missailidis. (2021) Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer Therapy. Pharmaceutics 13:8, pages 1239.
Crossref
Crossref
Fariba Maleki, Farzaneh Rezazadeh & Kambiz Varmira. (2021) MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy. Molecular Pharmaceutics 18:5, pages 1842-1861.
Crossref
Crossref
Juan Pellico, Peter J. Gawne & Rafael T. M. de Rosales. (2021) Radiolabelling of nanomaterials for medical imaging and therapy. Chemical Society Reviews 50:5, pages 3355-3423.
Crossref
Crossref
Dengfeng Li, Yesi Shi & Gang Liu. 2021. Aptamers for Medical Applications. Aptamers for Medical Applications
31
52
.
Marta de Souza Albernaz, Sergio Hiroshi Toma, Jeff Clanton, Koiti Araki & Ralph Santos-Oliveira. (2018) Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging. Pharmaceutical Research 35:1.
Crossref
Crossref
Jian Zhao, Keyao Tu, Yanlei Liu, Yulei Qin, Xiwei Wang, Lifeng Qi & Donglu Shi. (2017) Photo-controlled aptamers delivery by dual surface gold-magnetic nanoparticles for targeted cancer therapy. Materials Science and Engineering: C 80, pages 88-92.
Crossref
Crossref
Sofia Nascimento dos Santos, Sara Rhaissa Rezende dos Reis, Suyene Rocha Pinto, Cristal Cerqueira-Coutinho, Fiammetta Nigro, Thereza Christina Barja-Fidalgo, Nathalia Martins Alexandre Pinheiro, Heitor Affonso Paula Neto & Ralph Santos-Oliveira. (2017) Anti-inflammatory/infection PLA nanoparticles labeled with technetium 99m for in vivo imaging. Journal of Nanoparticle Research 19:10.
Crossref
Crossref
Lluis Pascual, Félix Sancenón, Ramón Martínez-Máñez, Thereza Christina Barja-Fidalgo, Simone Vargas da Silva, Ariane de Jesus Sousa-Batista, Cristal Cerqueira-Coutinho & Ralph Santos-Oliveira. (2017) Mesoporous silica as multiple nanoparticles systems for inflammation imaging as nano-radiopharmaceuticals. Microporous and Mesoporous Materials 239, pages 426-431.
Crossref
Crossref
Onat Kadioglu & Thomas Efferth. (2016) Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells. Investigational New Drugs 34:4, pages 515-521.
Crossref
Crossref
Marlies Gijs, An Aerts, Nathalie Impens, Sarah Baatout & André Luxen. (2016) Aptamers as radiopharmaceuticals for nuclear imaging and therapy. Nuclear Medicine and Biology 43:4, pages 253-271.
Crossref
Crossref
Wan Lu Li, Mi-Ra Lee & Mee-Yon Cho. (2016) The small molecule survivin inhibitor YM155 may be an effective treatment modality for colon cancer through increasing apoptosis. Biochemical and Biophysical Research Communications 471:2, pages 309-314.
Crossref
Crossref